METABOLISM OF NICOTINE TO COTININE STUDIED BY A DUAL STABLE-ISOTOPE METHOD

被引:404
作者
BENOWITZ, NL
JACOB, P
机构
[1] UNIV CALIF SAN FRANCISCO,DEPT MED,SAN FRANCISCO,CA
[2] UNIV CALIF SAN FRANCISCO,DEPT PSYCHIAT,SAN FRANCISCO,CA
[3] UNIV CALIF SAN FRANCISCO,DEPT PHARM,SAN FRANCISCO,CA
关键词
D O I
10.1038/clpt.1994.169
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Objectives: (1) To determine the disposition kinetics of nicotine and cotinine, including the fractional conversion of nicotine to cotinine, (2) to compare the disposition kinetics of deuterium-labeled and unlabeled cotinine, and (3) to develop a pharmacokinetically based method for estimating daily intake of nicotine from cigarette smoking. Study design: Twenty cigarette smokers received a combined infusion of deuterium-labeled nicotine (d(2)) and cotinine (d(4)). Six nonsmokers received a combined infusion of unlabeled cotinine, cotinine-d(2) and cotinine-d(4). Daily intake of nicotine was estimated with use of the plasma cotinine concentration during ad libitum smoking, clearance of labeled cotinine, and fractional conversion of nicotine to cotinine. Results: The kinetics of labeled versus unlabeled cotinine and of cotinine in smokers versus nonsmokers were similar. On average, 72% of nicotine was converted to cotinine, with a range from 55% to 92%. Subjects with lower clearances of nicotine had lower fractional conversion of nicotine to cotinine, indicating that this is the most rapid of the proximate metabolic pathways for nicotine. The equation for estimating daily intake of nicotine from smoking was: D-nic (mg/24 hr) = K x (Plasma Cot) (ng/ml), where K averaged 0.08, with a range from 0.047 to 0.102. Individual variability in the clearance of cotinine (coefficient of variation, 27.5%) accounts for more of the variability in K than does variability in the fractional conversion of nicotine to cotinine (coefficient of variation, 12.3%). Conclusions: Our study provides quantitative data on individual variability in the extent of C-oxidation of nicotine to cotinine and a quantitative perspective on the use of plasma cotinine as an indicator of daily intake of nicotine from tobacco.
引用
收藏
页码:483 / 493
页数:11
相关论文
共 23 条
[1]   SALIVA COTININE AS A MEASURE OF SMOKING STATUS IN FIELD SETTINGS [J].
ABRAMS, DB ;
FOLLICK, MJ ;
BIENER, L ;
CAREY, KB ;
HITTI, J .
AMERICAN JOURNAL OF PUBLIC HEALTH, 1987, 77 (07) :846-848
[2]   NONCOMPARTMENTAL DETERMINATION OF THE STEADY-STATE VOLUME OF DISTRIBUTION [J].
BENET, LZ ;
GALEAZZI, RL .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1979, 68 (08) :1071-1074
[3]   NICOTINE AND COTININE ELIMINATION PHARMACOKINETICS IN SMOKERS AND NONSMOKERS [J].
BENOWITZ, NL ;
JACOB, P .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1993, 53 (03) :316-323
[4]  
BENOWITZ NL, 1982, J PHARMACOL EXP THER, V221, P368
[5]  
BENOWITZ NL, 1994, J PHARMACOL EXP THER, V268, P296
[6]  
BENOWITZ NL, 1990, J PHARMACOL EXP THER, V254, P1000
[7]   SMOKERS OF LOW-YIELD CIGARETTES DO NOT CONSUME LESS NICOTINE [J].
BENOWITZ, NL ;
HALL, SM ;
HERNING, RI ;
JACOB, P ;
JONES, RT ;
OSMAN, AL .
NEW ENGLAND JOURNAL OF MEDICINE, 1983, 309 (03) :139-142
[8]   DAILY INTAKE OF NICOTINE DURING CIGARETTE-SMOKING [J].
BENOWITZ, NL ;
JACOB, P .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1984, 35 (04) :499-504
[9]   STABLE ISOTOPE STUDIES OF NICOTINE KINETICS AND BIOAVAILABILITY [J].
BENOWITZ, NL ;
JACOB, P ;
DENARO, C ;
JENKINS, R .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1991, 49 (03) :270-277
[10]  
Benowitz NL, 1984, NIDA RES MONOGR, V48, P6